<--- Back to Details
First PageDocument Content
Factor VIII / Moroctocog alfa / Von Willebrand disease / Coagulation / Factor VII / Haemophilia / Factor X / Von Willebrand factor / Coagulation system / Blood / Anatomy
Date: 2014-04-23 17:31:30
Factor VIII
Moroctocog alfa
Von Willebrand disease
Coagulation
Factor VII
Haemophilia
Factor X
Von Willebrand factor
Coagulation system
Blood
Anatomy

Hemophilia Enhanced Specialty Discount Products Published_05[removed]xls

Add to Reading List

Source URL: www.ncdhhs.gov

Download Document from Source Website

File Size: 11,64 KB

Share Document on Facebook

Similar Documents

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Microsoft Wordfile00

Microsoft Wordfile00

DocID: 1r9dZ - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

RECOTHROM, Thrombin topical (Recombinant) Package Insert

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document